Cyclarity Therapeutics

Cyclarity Therapeutics, Inc. develops simple and direct interventions targeting oxidized cholesterol using rationally designed molecules, offering the first true disease-modifying treatment for common age-related conditions such as atherosclerosis, heart attacks, and strokes. Its products are based on novel derivatives of a well-established safe compound and a new approach to observing cardiovascular diseases.